# A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes

> **NCT00672386** · PHASE2 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 352 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Diabetes Mellitus
- Endocrine System Diseases
- Nutritional and Metabolic Diseases

## Interventions

- **DRUG:** JNJ16269110
- **DRUG:** JNJ16269110
- **DRUG:** JNJ16269110
- **DRUG:** Placebo
- **DRUG:** Metformin
- **OTHER:** Dietary Counseling

## Key facts

- **NCT ID:** NCT00672386
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672386, "A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00672386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*